Bank of New York Mellon’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-92,720
Closed -$120K 4379
2026
Q1
$120K Sell
92,720
-67
-0.1% -$111 ﹤0.01% 4082
2025
Q4
$205K Sell
92,787
-3,391
-4% -$6.38K ﹤0.01% 4016
2025
Q3
$156K Buy
96,178
+332
+0.3% +$695 ﹤0.01% 4063
2025
Q2
$248K Sell
95,846
-26,455
-22% -$104K ﹤0.01% 3893
2025
Q1
$823K Sell
122,301
-13,139
-10% -$93K ﹤0.01% 3170
2024
Q4
$920K Buy
135,440
+64
+0% +$421 ﹤0.01% 3209
2024
Q3
$1.12M Sell
135,376
-22,526
-14% -$163K ﹤0.01% 3080
2024
Q2
$1M Buy
157,902
+17,740
+13% +$136K ﹤0.01% 3202
2024
Q1
$1.3M Sell
140,162
-13,369
-9% -$157K ﹤0.01% 3007
2023
Q4
$1.96M Sell
153,531
-6,181
-4% -$64.4K ﹤0.01% 2845
2023
Q3
$1.65M Buy
159,712
+3,900
+3% +$45.2K ﹤0.01% 2914
2023
Q2
$2.04M Buy
155,812
+3,104
+2% +$38K ﹤0.01% 2821
2023
Q1
$1.71M Sell
152,708
-961
-0.6% -$9.49K ﹤0.01% 2885
2022
Q4
$1.3M Buy
153,669
+42,396
+38% +$403K ﹤0.01% 3072
2022
Q3
$1.85M Buy
111,273
+14,319
+15% +$264K ﹤0.01% 2907
2022
Q2
$1.43M Buy
96,954
+14,029
+17% +$289K ﹤0.01% 3024
2022
Q1
$2.06M Buy
82,925
+26
+0% +$671 ﹤0.01% 2923
2021
Q4
$2.66M Buy
82,899
+234
+0.3% +$8.55K ﹤0.01% 2823
2021
Q3
$2.97M Buy
82,665
+6,706
+9% +$264K ﹤0.01% 2769
2021
Q2
$3.35M Buy
75,959
+42,848
+129% +$1.87M ﹤0.01% 2686
2021
Q1
$1.51M Buy
33,111
+3,117
+10% +$179K ﹤0.01% 3086
2020
Q4
$2.07M Buy
+29,994
New +$1.47M ﹤0.01% 2824

Other funds holding LUNG

Bank of New York Mellon's LUNG Position: Q2 2026 in Review

Bank of New York Mellon sold out of Pulmonx (LUNG) in Q2 2026, closing a stake of 92,720 shares — an estimated $120K sold.

Bank of New York Mellon first reported a position in LUNG in Q4 2020 and held it in 22 quarters. The position peaked at $3.35M in Q2 2021. 42 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Bank of New York Mellon reported no remaining Pulmonx position as of Q2 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 92,720 Pulmonx shares in Q2 2026, an estimated $120K.
  • Bank of New York Mellon first reported a position in Pulmonx in Q4 2020 and held it in 22 quarters.
  • Bank of New York Mellon's Pulmonx position peaked at $3.35M in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.